LABU News and Press, Direxion Daily S&P Biotech Bull 3X Shares From 01/22/26

2026-01-22 06:07:00 ET By Vinay Thapar, CFA and Jane Bleeg More clarity on regulatory and policy issues can help healthcare stocks reassert their fundamental strengths. Read the full article on Seeking Alpha For further details see: Are Healthcare Stocks Pois...

2026-01-20 12:39:50 ET Fast facts and strategy of the Direxion Daily Healthcare Bull 3x Shares ETF The Direxion Daily Healthcare Bull 3X Shares ETF ( CURE ) is a leveraged ETF with a factor of 3x in the healthcare sector. CURE was launched on June 15, 2011 and has a net expense ...

2026-01-13 06:30:00 ET Transcript We just had three years of double-digit returns for S&P 500 that is quite rare, and if we make it into four depends a lot on earnings. Q4 is starting to report, and there are three themes on my mind.... Read the full article on...

A look at the top 10 most actives in the United States Aspire Biopharma Holdings Inc. (ASBP) rose 19.6% to $0.1256 on volume of 510,585,131 shares Oriental Culture Holding LTD (OCG) rose 5.9% to $0.0235 on volume of 398,743,181 shares Hyperscale Data Inc. (GPUS) rose 40.7% to $0.3604 on vol...

2026-01-08 05:30:00 ET After a prolonged slump, investors are giving the healthcare sector a second look as lower interest rates, potential M&A and even AI innovation help to improve the outlook. Jacky He, Vice President for Portfolio Research at TD Asset Management, joins MoneyTalk...

A look at the top 10 most actives in the United States Aspire Biopharma Holdings Inc. (ASBP) rose 25.7% to $0.132 on volume of 489,285,248 shares Oriental Culture Holding LTD (OCG) fell 2.7% to $0.0216 on volume of 336,903,531 shares Hyperscale Data Inc. (GPUS) rose 44.5% to $0.3703 on volu...

2026-01-02 10:04:54 ET ... Read the full article on Seeking Alpha For further details see: Leveraged ETF Drift Watch List And Focus On SQQQ

2025-12-23 11:02:44 ET More on Direxion Daily S&P Biotech Bull 3X Shares LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF Seeking Alpha’s Quant Rating on Direxion Daily S&P Biotech Bull 3X Shares Dividend scorecard for Direxion Daily S&...

2025-12-19 03:10:00 ET By Frank Coughlin A clear story has emerged from the third quarter earnings season - one of divergence. We are seeing a market split between companies benefiting from major secular growth trends and those navigating more traditional economic cycles.... ...

2025-12-17 12:29:56 ET Fast Facts About the Direxion Daily S&P Biotech Bull 3X ETF Read the full article on Seeking Alpha For further details see: LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF